Literature DB >> 1899927

Amyloid precursor protein in aged nonhuman primates.

L J Martin1, S S Sisodia, E H Koo, L C Cork, T L Dellovade, A Weidemann, K Beyreuther, C Masters, D L Price.   

Abstract

In individuals with Alzheimer disease and in aged nonhuman primates, deposits of amyloid occur in senile plaques in brain parenchyma and in the walls of some meningeal and cortical vessels. Amyloid is primarily composed of beta/A4, a 4-kDa peptide derived from the transmembrane form of an amyloid precursor protein (APP). We examined the distribution of beta/A4 and APP (outside the beta/A4 domain) in cerebral cortices of monkeys ranging in age from 4 to 41 years. In all animals, APP immunoreactivity was present in cell bodies, proximal dendrites, and axons of cortical neurons. In aged animals, all of which showed senile plaques, large APP-positive axons were conspicuous, and APP immunoreactivity was present in neurites around beta/A4-immunoreactive plaques. In some plaques, APP-immunoreactive elements were located in proximity to deposits of beta/A4. The presence of APP immunoreactivity in neuronal perikarya, dendrites, axons, and in neurites within beta/A4-containing plaques supports the hypothesis that neurons can serve as one source of amyloid deposited in brain parenchyma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899927      PMCID: PMC51038          DOI: 10.1073/pnas.88.4.1461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

Review 2.  New perspectives on Alzheimer's disease.

Authors:  D L Price
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

3.  Amyloid precursor protein in senile plaques of Alzheimer disease.

Authors:  G Perry; S Lipphardt; P Mulvihill; M Kancherla; M Mijares; P Gambetti; S Sharma; L Maggiora; J Cornette; T Lobl
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

4.  The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.

Authors:  T Oltersdorf; L C Fritz; D B Schenk; I Lieberburg; K L Johnson-Wood; E C Beattie; P J Ward; R W Blacher; H F Dovey; S Sinha
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

5.  Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

Authors:  W E Van Nostrand; S L Wagner; M Suzuki; B H Choi; J S Farrow; J W Geddes; C W Cotman; D D Cunningham
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations.

Authors:  M N Hart; P Merz; J Bennett-Gray; A H Menezes; J A Goeken; R L Schelper; H M Wisniewski
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

7.  Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.

Authors:  M R Palmert; T E Golde; M L Cohen; D M Kovacs; R E Tanzi; J F Gusella; M F Usiak; L H Younkin; S G Younkin
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

8.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

9.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

10.  Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle.

Authors:  K Zimmermann; T Herget; J M Salbaum; W Schubert; C Hilbich; M Cramer; C L Masters; G Multhaup; J Kang; H G Lemaire
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  33 in total

Review 1.  Amyloidosis in aging and Alzheimer's disease.

Authors:  D L Price; L C Walker; L J Martin; S S Sisodia
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Authors:  Sungho Lee; Nicholas H Varvel; Megan E Konerth; Guixiang Xu; Astrid E Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

Review 3.  Nonhuman primate models of Alzheimer-like cerebral proteopathy.

Authors:  Eric Heuer; Rebecca F Rosen; Amarallys Cintron; Lary C Walker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Beyond counts and shapes: studying pathology of dendritic spines in the context of the surrounding neuropil through serial section electron microscopy.

Authors:  M Kuwajima; J Spacek; K M Harris
Journal:  Neuroscience       Date:  2012-05-01       Impact factor: 3.590

5.  Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.

Authors:  D Wu; J Yang; W M Pardridge
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

Authors:  Y Saito; J Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 7.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

Authors:  Nicholas H Varvel; Kiran Bhaskar; Maria Z Kounnas; Steven L Wagner; Yan Yang; Bruce T Lamb; Karl Herrup
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

Review 9.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22

10.  The distribution of amyloid beta precursor protein in canine brain.

Authors:  R Okuda; K Uchida; S Tateyama; R Yamaguchi; H Nakayama; N Goto
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.